CHAIRPERSON: William K. Schmidt, Ph.D., President, NorthStar Consulting, LLC, VP Clinical & Regulatory, Centrexion Corp., VP Clinical & Regulatory, Cap Genesis, LLC, VP Clinical Development, EicOsis, LLC
Jon Levine, MD, Ph.D., Professor of Medicine, University of California, San Francisco
Anthony Ford, Ph.D., Chief Scientific Officer, Afferent Pharmaceuticals
Thomas Kornecook, Ph.D., Principal Scientist, Department of Neuroscience, Amgen, Inc.
Doo Lee, Ph.D., Chief Executive Officer, Vivozon
Ed Bilsky, Ph.D., Professor of Pharmacology, COM, Vice President of Research and Scholarship, University of New England
Steve Harrison, Ph.D., Vice President, Research Biology, Nektar Therapeutics
David Yeomans, Ph.D., Director of Pain Research, Faculty of Anesthesia, Stanford University School of Medicine, Founder & Chief Scientist, Trigemina, Inc.
Cheryl Hankin, Ph.D., President and Chief Scientific Officer, BioMedEcon, LLC
Leon Garcia-Martinez, Ph.D., Senior Director Target Biology, Alder Biopharmaceuticals
Theodore Price, Ph.D., Associate Professor, School of Behavioral and Brain Sciences, University of Texas at Dallas
Gaetano Scuderi, MD, Founder, President, Cytonics Corporation
Nader Ghasemlou, Ph.D., Research Fellow, Children's Hospital Boston & Harvard Medical School, F.M. Kirby Neurobiology Center
Neil Singla, MD, Founder & Chief Scientific Officer, Lotus Clinical Research
Mike Royal, MD, JD, MBA, Executive VP, Clinical & Regulatory Affairs, Sorrento Therapeutics, Inc.
Ernest A. Kopecky, Ph.D., MBA, VP Clinical Development | Head, Neuroscience TA, COLLEGIUM Pharmaceutical
Lee M. Techner, DPM, Principal and Chief Clinical Consultant, Stage Gate Partners
Daniel Legault, JD, Chief Executive Officer and Director, Antibe Therapeutics
Brian Meshkin, Founder and President, Proove Biosciences
